Skip Navigation

Human Molecular Genetics 2005 14(Review Issue 2):R191-R196; doi:10.1093/hmg/ddi266
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Muntoni, A.
Right arrow Articles by Reddel, R. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Muntoni, A.
Right arrow Articles by Reddel, R. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press. All rights reserved.
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact: journals.permissions@oxfordjournals.org

The first molecular details of ALT in human tumor cells

Alessandra Muntoni and Roger R. Reddel*

Cancer Research Unit, Children's Medical Research Institute, 214 Hawkesbury Road, Westmead, Sydney, New South Wales 2145, Australia

* To whom correspondence should be addressed. Tel: +61 296872800; Fax: +61 296872120; Email: rreddel{at}cmri.usyd.edu.au

Received June 15, 2005; Accepted July 14, 2005

The activation of a telomere maintenance mechanism (TMM) is indispensable for cellular immortalization, a hallmark of human cancer. Although most human cancers use telomerase as their TMM, some use an alternative lengthening of telomeres (ALT) mechanism. The latter especially include specific subtypes of soft tissue sarcomas where ALT occurs most often in tumors with complex karyotypes, astrocytic brain tumors and osteosarcomas. The prognostic significance of ALT varies according to the type of tumor. Some ALT cells have atypical features, suggesting the possibility that there is more than one ALT mechanism. ALT cells are characterized by instability at a specific minisatellite locus (although they are stable at microsatellite loci) and by high rates of telomeric recombinational exchange. We propose a revised model whereby unequal telomeric exchange and asymmetrical chromosome segregation could result in telomere length maintenance in a cell population. In at least some ALT cells, telomere maintenance requires the integrity of the MRN (MRE11-RAD50-NBS1) recombination complex and is efficiently repressed by its sequestration. Microsatellite instability (MSI) often results in disruption of MRN, so ALT may usually be incompatible with MSI. We suggest that ALT in human tumors is a dysregulated version of an aspect of normal mammalian telomere homeostasis, which may be a vestige of the TMM used by ancient eukaryotes. Understanding the molecular basis of ALT has important implications for the diagnosis and treatment of tumors that use this TMM.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 JCBHome page
W.-Q. Jiang, Z.-H. Zhong, A. Nguyen, J. D. Henson, C. D. Toouli, A. W. Braithwaite, and R. R. Reddel
Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins
J. Cell Biol., June 1, 2009; 185(5): 797 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
T. Jegou, I. Chung, G. Heuvelman, M. Wachsmuth, S. M. Gorisch, K. M. Greulich-Bode, P. Boukamp, P. Lichter, and K. Rippe
Dynamics of Telomeres and Promyelocytic Leukemia Nuclear Bodies in a Telomerase-negative Human Cell Line
Mol. Biol. Cell, April 1, 2009; 20(7): 2070 - 2082.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
A. Muntoni, A. A. Neumann, M. Hills, and R. R. Reddel
Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres
Hum. Mol. Genet., March 15, 2009; 18(6): 1017 - 1027.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
P. Munoz, R. Blanco, G. de Carcer, S. Schoeftner, R. Benetti, J. M. Flores, M. Malumbres, and M. A. Blasco
TRF1 Controls Telomere Length and Mitotic Fidelity in Epithelial Homeostasis
Mol. Cell. Biol., March 15, 2009; 29(6): 1608 - 1625.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. H. Bechard, B. D. Butuner, G. J. Peterson, W. McRae, Z. Topcu, and M. J. McEachern
Mutant Telomeric Repeats in Yeast Can Disrupt the Negative Regulation of Recombination-Mediated Telomere Maintenance and Create an Alternative Lengthening of Telomeres-Like Phenotype
Mol. Cell. Biol., February 1, 2009; 29(3): 626 - 639.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
I. Jaco, A. Canela, E. Vera, and M. A. Blasco
Centromere mitotic recombination in mammalian cells
J. Cell Biol., October 21, 2008; 181(6): 885 - 892.
[Abstract] [Full Text] [PDF]

Home page
 Nucleic Acids ResHome page
J. Tang, Z.-y. Kan, Y. Yao, Q. Wang, Y.-h. Hao, and Z. Tan
G-quadruplex preferentially forms at the very 3' end of vertebrate telomeric DNA
Nucleic Acids Res., March 27, 2008; 36(4): 1200 - 1208.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
L. Subramanian, B. A. Moser, and T. M. Nakamura
Recombination-Based Telomere Maintenance Is Dependent on Tel1-MRN and Rap1 and Inhibited by Telomerase, Taz1, and Ku in Fission Yeast
Mol. Cell. Biol., March 1, 2008; 28(5): 1443 - 1455.
[Abstract] [Full Text] [PDF]

Home page
 Genes Dev.Home page
M. P. Longhese
DNA damage response at functional and dysfunctional telomeres
Genes & Dev., January 15, 2008; 22(2): 125 - 140.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
M. Stagno D'Alcontres, A. Mendez-Bermudez, J. L. Foxon, N. J. Royle, and P. Salomoni
Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA
J. Cell Biol., December 3, 2007; 179(5): 855 - 867.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
B. L. Pike and J. Heierhorst
Mdt1 Facilitates Efficient Repair of Blocked DNA Double-Strand Breaks and Recombinational Maintenance of Telomeres
Mol. Cell. Biol., September 15, 2007; 27(18): 6532 - 6545.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
R. Benetti, S. Gonzalo, I. Jaco, G. Schotta, P. Klatt, T. Jenuwein, and M. A. Blasco
Suv4-20h deficiency results in telomere elongation and derepression of telomere recombination
J. Cell Biol., September 7, 2007; 178(6): 925 - 936.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
R. T. Calado, S. A. Graf, K. L. Wilkerson, S. Kajigaya, P. J. Ancliff, Y. Dror, S. J. Chanock, P. M. Lansdorp, and N. S. Young
Mutations in the SBDS gene in acquired aplastic anemia
Blood, August 15, 2007; 110(4): 1141 - 1146.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. S. Multani and S. Chang
WRN at telomeres: implications for aging and cancer
J. Cell Sci., March 1, 2007; 120(5): 713 - 721.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. A. Compton, J.-H. Choi, A. J. Cesare, S. Ozgur, and J. D. Griffith
Xrcc3 and Nbs1 Are Required for the Production of Extrachromosomal Telomeric Circles in Human Alternative Lengthening of Telomere Cells
Cancer Res., February 15, 2007; 67(4): 1513 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Xhemalce, E. M. Riising, P. Baumann, A. Dejean, B. Arcangioli, and J.-S. Seeler
Role of SUMO in the dynamics of telomere maintenance in fission yeast
PNAS, January 16, 2007; 104(3): 893 - 898.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.